Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM) -- Ignore unavailable to you. Want to Upgrade?

To: Starowl who wrote (413)	11/28/2001 2:38:55 PM
From: Dick Martin	Respond to of 655

I guess this will be going on a fast track, apparently there are some other contenders for this market. Here is the fact sheet which tells a little more about the Anthrax test. FACT SHEET Biomedical Corp. 8855 Northbrook Court Burnaby, British Columbia Canada V5J 5J1 November 28, 2001 The RAMPTM System The RAMP diagnostic System is a sensitive, rapid platform designed to perform quantitative immunoassays with the level of analytical sensitivity found in expensive, lab-based systems, in less than 15 minutes. It is an ideal platform to perform environmental tests for infectious agents such as anthrax and other biological materials where rapid on-site testing is needed. The RAMP Anthrax Test is a semi-quantitative immunochromatographic test for the detection of Bacillus anthracis. A sample containing suspect material is obtained on a swab or on a filter for air sampling. The swab or filter is placed into a tube which is sealed and shaken. A sample of the liquid is removed from the tube and placed into the sample well of the RAMP Cartridge. The RAMP cartridge is placed into the RAMP Reader and a semi-quantitative result automatically appears within 15 minutes. Estimated US Anthrax Test Market US Public Safety Customers:No of Sites:Postal Outlets39,000Hospitals6,200Campus Law Enforcement600Fire departments26,354Police departments18,769Total US market size90,923 The environmental anthrax test market in the U.S. would include over 2 million public safety workers that need to be trained on emergency preparedness. We estimate the U.S. public safety market for the environmental detection of anthrax to be in excess of US$500 million in the next two years. For Further Information Contact: Bill Radvak President & CEO Response Biomedical Corp. Tel: 604 681-4101 Fax: 604 412-9830 HYPERLINK "mailto:jgomez@responsebio.com" bradvak@responsebio.com